Dr. Kerchner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
# MC5235
Stanford, CA 94305Phone+1 650-723-6469Fax+1 650-723-7434
Education & Training
- University of California (San Francisco)Residency, Neurology, 2004 - 2007
- University of California (San Francisco)Internship, Internal Medicine, 2003 - 2004
- Washington University in St. Louis School of MedicineClass of 2003
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- CA State Medical License 2005 - 2027
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Plasma Aβ/Aβis sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum.Alexandra N Trelle, Christina B Young, Hillary Vossler, Javier Ramos Benitez, Karly A Cody
Alzheimer's & Dementia. 2024-12-23 - Biologically defined neuronal synuclein disease as a tool to advance drug development.Gennaro Pagano, Tien Dam, Geoffrey A Kerchner, Wendy R Galpern, Milton Biagioni
NPJ Parkinson's Disease. 2024-12-20 - 1 citationsSustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.Gennaro Pagano, Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda
Nature Medicine. 2024-12-01
Journal Articles
- Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration StudyLu Tian, Gayle K Deutsch, Geoffrey A Kerchner, Sharon J Sha, JAMA
- Individual Differences in Associative Memory Among Older Adults Explained by Hippocampal Subfield Structure and FunctionGeoffrey Kerchner, MD, Proceedings of the National Academy of Sciences
Press Mentions
- Anti-Tau Antibody Data Leave Best Isotype UnclearMay 14th, 2021
- Iceberg of Lost MemoriesMay 28th, 2020
- Diagnosing Alzheimer’s: Medicare Now Pays Doctors to Stop and Assess Memory LossJanuary 4th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: